This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Clinuvel Pharmaceuticals Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovations of Stuart Michael Humphrey
Introduction
Stuart Michael Humphrey is an accomplished inventor based in Hampton, Australia. He has made significant contributions to the field of dermatology through his innovative research and development of methods to enhance skin pigmentation.
Latest Patents
One of his notable patents is titled "Method of inducing melanogenesis in humans with MC1R variant alleles." This patent describes a method for inducing melanogenesis in human subjects who possess a melanocortin 1 receptor (MC1R) variant allele associated with diminished receptor function. The method involves administering an effective amount of an α-melanocyte stimulating hormone (α-MSH) analogue to stimulate melanogenesis in the skin or other epidermal tissues of the subject.
Career Highlights
Stuart is currently associated with Clinuvel Pharmaceuticals Limited, a company known for its focus on developing innovative therapies for skin disorders. His work has been instrumental in advancing the understanding of skin pigmentation and its implications for individuals with specific genetic variations.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Stuart Michael Humphrey's contributions to the field of dermatology through his innovative patent demonstrate his commitment to improving skin health and understanding genetic influences on pigmentation. His work continues to pave the way for future advancements in this important area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile